𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Evaluation of prostate-specific antigen, digital rectal examination and transrectal ultrasonography in population-based screening for prostate cancer: improving the efficiency of early detection

✍ Scribed by J.B.W. RIETBERGEN; R. KRANSE; W.J. KIRKELS; H.J. DE KONING; F H SCHRÖDER


Book ID
109050738
Publisher
John Wiley and Sons
Year
1997
Tongue
English
Weight
673 KB
Volume
79
Category
Article
ISSN
1464-4096

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Prostate-specific antigen coordinated wi
✍ W. H. Cooner 📂 Article 📅 1993 🏛 Springer-Verlag 🌐 English ⚖ 349 KB

In a aptient population, coordinated use of digital rectal examination and prostate-specific antigen can alert the physician as to the possible existence of prostate cancer. If both are used as first-line studies, abnormality of either can then direct the need for further study by transrectal ultras

Evaluation of prostatic specific antigen
✍ Bernard Candas; Lionel Cusan; Jose-Luis Gomez; Pierre Diamond; Raul E. Suburu; J 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 341 KB 👁 2 views

## BACKGROUND. The 11,811 first visits and 46,751 annual follow-up visits performed since 1988 were analyzed in order to assess the efficacy of serum prostatic specific antigen (PSA) and digital rectal examination (DRE) for diagnosis of prostate cancer. METHODS. At first visit, screening included

Prostate-specific antigen, digital recta
✍ Dr. Joseph R. Drago; Jeffrey P. York 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 331 KB

Over a 4% year period, 1,940 asymptomatic men were entered in a prostate cancer detection program consisting of digital rectal examination (DRE), prostate-specific antigen (PSA), and transrectal prostate ultrasound (TRUS). Four hundred and sixteen biopsies were performed resulting in the diagnosis o

The role of digital rectal examination,
✍ Fred Lee; Peter J. Littrup 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 389 KB

In a study population, can digital rectal examination (DRE), transrectal ultrasound (TRUS), and prostate specific antigen (PSA) (monoclonal) effectively detect the majority of clinically relevant cancer? If this is possible, the remaining patients could then be considered for chemopreventive protoco